Search Results
Oct 20, 2025, 10:23 ET Kanazawa University Research: From Molecular Interactions to Material Function: Unraveling Water's Effect on Chitin Nanocrystals
gratefully acknowledged. We thank the captain and crew of R/V Yokosuka for their great support of scientific activity during the expedition YK21-18C (PI: Dr. Hidetaka Nomaki). We extend thanks to the DSV Shinkai 6500 team. We thank the NIES for providing us the culture of Phaeocystis globosa
More news about: Kanazawa University
Oct 17, 2025, 11:45 ET PHYSICIANS INSURANCE A MUTUAL COMPANY NAMES DR. DAVID CARLSON PRESIDENT AND CEO
with him as PI moves into its next chapter. I also want to extend my gratitude to Bill for his tremendous leadership and his service to our Members during his successful tenure." William Cotter has served as President and CEO of PI since 2019. During his time at PI, he has led the
More news about: Physicians Insurance
Oct 17, 2025, 03:52 ET C2A Security acquiert Vigilant Ops et crée un leader mondial de la sécurité des produits optimisée par l'IA, ajoutant des dizaines de clients medtech, télécoms et de la défense
composants améliore le délai de rentabilité et réduit les cycles de remédiation coûteux. Un portefeuille de PI renforcé : combine le SBOM et la PI de conformité de Vigilant Ops avec les capacités AI-SOAR de C2A Security pour fournir des décisions plus rapides et plus précises à
More news about: C2A Security
Oct 16, 2025, 17:31 ET Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight
For relapsed or refractory cases, targeted therapies play a central role, including BTK inhibitors (e.g., ibrutinib, zanubrutinib), PI3K inhibitors (e.g., copanlisib, duvelisib, umbralisib), and EZH2 inhibitors like tazemetostat, particularly in EZH2-mutated follicular lymphoma. In more
More news about: DelveInsight Business Research, LLP
Oct 16, 2025, 15:31 ET Blokees présente de nouveaux produits à l'occasion de la China Toy Expo 2025, continuant à améliorer la compétitivité de ses produits
2025, a été présentée avec une plus grande quantité de produits. La série C, destinée aux fans de PI généraliste, présentait des designs d'Ultraman. La série E, qui s'adresse aux adultes amateurs de PI, présentait des produits inspirés de Fast & Furious. Il s'agit notamment de la première commercialisation
More news about: Blokees
Oct 16, 2025, 10:10 ET Celebração do quinquagésimo aniversário da Linglong Tire realizada com sucesso em Madrid
emocionante foi a interação ao vivo com a lenda do Real Madrid, Roberto Carlos, que elevou a atmosfera ao ápice. Colaborar com uma PI de renome internacional como o Real Madrid é um reflexo estratégico dos esforços contínuos da Linglong para aprofundar sua presença nos mercados europeus
More news about: Shandong Linglong Tyre Co., Ltd.
Oct 16, 2025, 08:59 ET Lindus Health Partners with Yendou to Streamline Site Engagement and Accelerate Clinical Trial Feasibility
automation and persistent memory, Lindus Health can focus on connection-building interactions, including increased site calls, early Principal Investigator (PI) input on studies to support protocol development, and transparent pipeline visibility. The outcomes of this partnership speak
More news about: Lindus Health
Oct 16, 2025, 08:00 ET TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
useful in certain circumstances for early relapse patients after at least three prior therapies, including a PI and an immunomodulatory agent, or for patients who are double refractory to a PI and an immunomodulatory agent. For more information, visit
More news about: Johnson & Johnson
Oct 15, 2025, 09:00 ET Four in Five Employees Feel Positive About AI, but Only Half Believe Their Feedback Shapes Adoption, New Survey Finds
Predictive IndexThe Predictive Index (PI) is the data-driven HR platform to hire top performers, develop effective managers, and retain your people. More than 60 years of proven science, software, and a curriculum of insightful management workshops make PI the solution for any company looking to design
More news about: The Predictive Index
Oct 15, 2025, 09:00 ET GC Biopharma Announces Symposium on Clinical and Patient Experience in Primary Immunodeficiency and Poster Presentations on IVIG Manufacturing and Viscosity at the 2025 IgNS Annual Meeting
www.gcbiopharma.us. INDICATIONALYGLO® is indicated for the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich
More news about: GC Biopharma USA Inc.
Oct 14, 2025, 14:48 ET InPsytech presenta la tecnología UCIe 3.0 de 3 nm en OCP 2025
14 de octubre de 2025 /PRNewswire/ -- InPsytech, filial de Egis Technology (6462.TWO), especializada en el desarrollo de propiedad intelectual (PI) de interfaces de alta velocidad, anunció hoy su participación en la Cumbre Global 2025 del Open Compute Project (OCP), que se celebrará en San José,
More news about: InPsytech
Oct 14, 2025, 10:13 ET Large Aperture Air Bearing Rotation Stage - A-688, Made in the USA
More information on US-Manufactured Air Bearings by PI PI Americas
More news about: PI (Physik Instrumente) LP
Oct 14, 2025, 09:32 ET iOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO
changing the outlook for patients and their families. Lead asset, roginolisib, is an allosteric modulator of PI3Kδ with a unique chemical structure and binding mode. Allosteric modulation is a new archetype for precise inhibition of PI3Kδ, promising clinical activity without the detrimental tolerability seen with previous
More news about: iOnctura
Oct 13, 2025, 09:00 ET GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
manufacturing. ALYGLO® is approved by the U.S. Food and Drug Administration (FDA) for the treatment of primary humoral immunodeficiency (PI) in adults aged 17 and older. ALYGLO® is supported by GC Biopharma's 50-year legacy in plasma product manufacturing with immune globulin therapies distributed
More news about: GC Biopharma USA Inc.
Oct 13, 2025, 06:45 ET Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
oral, next-generation inhibitor phosphoinositide 3-kinase alpha (PI3Kα) inhibitor designed to selectively target tumors with PIK3CA mutations while sparing wild-type PI3Kα. Activating mutations in the PIK3CA gene (which encodes PI3Kα enzyme) are oncogenic drivers present in approximately 40%
More news about: Eli Lilly and Company
Oct 09, 2025, 12:13 ET YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI
of PI in patients aged 2 years and older. Developed by Biotest AG, a part of the Grifols group, YIMMUGO represents an innovation in immunoglobulin (Ig) therapy. In 2024, Biotest AG granted Kedrion Biopharma exclusive rights to commercialize YIMMUGO in the United States. PI refers
More news about: Kedrion Biopharma
Oct 09, 2025, 07:43 ET Dun & Bradstreet Celebrates Visionary Finance Leaders at the Finance Leadership Summit 2025
PI Industries Limited
More news about: Dun & Bradstreet India
Oct 08, 2025, 06:30 ET Everest Group Recognizes Shift Technology as a Top 10 High Potential Payment Integrity Specialist
According to Everest Group, "the Payment Integrity (PI) market is structurally resetting. Payers are moving from retrospective audits to preventive, pre-payment validation using AI, predictive analytics,
More news about: Shift Technology
Oct 07, 2025, 09:00 ET Golden Helix Receives a NIH SBIR Phase 2 Grant
responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The PI of this grant, Dr. Andreas Scherer, President and CEO of Golden Helix, expressed his appreciation, "We are extremely grateful for the long-standing support
More news about: Golden Helix Inc
Oct 07, 2025, 08:30 ET Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
approximately 15 months. Kazia also intends to explore synergistic opportunities to combine NDL2 with its existing pipeline assets, including paxalisib (a pan-PI3K/mTOR inhibitor) and EVT801 (a selective VEGFR3 inhibitor), given their complementary mechanisms of action in modulating the tumor microenvironment.
More news about: Kazia Therapeutics Limited
Oct 07, 2025, 08:13 ET US-Manufactured High Performance Linear Positioning Stage Family with Absolute Encoder and Excellent Guiding Precision
AUBURN, Mass., Oct. 7, 2025 /PRNewswire/ -- Global precision motion control and nanopositioning industry leader PI has expanded its portfolio with a new high dynamics linear motor stage family, the V-573 - a new series of linear positioning stages with excellent guiding
More news about: PI (Physik Instrumente) LP
Oct 07, 2025, 03:19 ET Prepare-se para a "MAIOR SURPRESA" de 2025 da Gravity
A Gravity foi fundada em abril de 2000 como uma empresa sul-coreana de jogos listada na NASDAQ. Sua principal PI, "Ragnarok", alcançou mais de 203 milhões de contas registradas globalmente (em 31 de agosto de 2024) e tem sido classificada como o segundo jogo coreano
More news about: Gravity
Oct 06, 2025, 12:14 ET New Survey: Most Americans Believe Plasma Donation Saves Lives, Yet Few Have Donated
Americans have been diagnosed with a primary immunodeficiency (PI), though the actual number is likely much higher due to widespread underdiagnosis," said Jorey Berry, President and CEO of the Immune Deficiency Foundation. "Many individuals with PI depend on life-saving plasma-derived medicines that cannot
More news about: The Plasma Protein Therapeutics Association
Oct 06, 2025, 08:00 ET Indigo Ag Introduces biotrinsic® Nemora FP™
market. "Nemora is another important tool against the SCN threat and growing resistance to SCN traits like PI 88788. As a biological seed treatment, it helps manage nematode pressure by stopping egg hatch and can deliver season-long benefits," Giebel added.
More news about: Indigo Agriculture
Oct 06, 2025, 06:05 ET Ryght AI to Showcase AI-Powered Clinical Research Platform as Featured Solution Partner in Microsoft Booth at HLTH 2025
models of every clinical research site globally. Each AI Site Twin captures the individual operational characteristics, historical trial performance, PI expertise, and regulatory history of each individual clinical research site. This innovative approach enables sponsors and CROs to automate traditionally
More news about: Ryght